Brief: Chiesi Global Rare Diseases And Protalix Biotherapeutics Announce European Commission Authorization Of PRX-10205/05/2023 12:31
Brief: Protalix Biotherapeutics Reports First Quarter 2023 Financial And Business Results04/05/2023 12:17
Last trade - 00:00Last trade - 00:00Last trade - 00:00